Cargando…
Potential Cancer- and Alzheimer’s Disease-Targeting Phosphodiesterase Inhibitors from Uvaria alba: Insights from In Vitro and Consensus Virtual Screening
[Image: see text] Inhibition of the major cyclic adenosine monophosphate-metabolizing enzyme PDE4 has shown potential for the discovery of drugs for cancer, inflammation, and neurodegenerative disorders such as Alzheimer’s disease. As a springboard to explore new anti-cancer and anti-Alzheimer’s che...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015132/ https://www.ncbi.nlm.nih.gov/pubmed/33817501 http://dx.doi.org/10.1021/acsomega.1c00137 |
_version_ | 1783673624573509632 |
---|---|
author | Quimque, Mark Tristan Notarte, Kin Israel Letada, Arianne Fernandez, Rey Arturo Pilapil, Delfin Yñigo Pueblos, Kirstin Rhys Agbay, Jay Carl Dahse, Hans-Martin Wenzel-Storjohann, Arlette Tasdemir, Deniz Khan, Abbas Wei, Dong-Qing Gose Macabeo, Allan Patrick |
author_facet | Quimque, Mark Tristan Notarte, Kin Israel Letada, Arianne Fernandez, Rey Arturo Pilapil, Delfin Yñigo Pueblos, Kirstin Rhys Agbay, Jay Carl Dahse, Hans-Martin Wenzel-Storjohann, Arlette Tasdemir, Deniz Khan, Abbas Wei, Dong-Qing Gose Macabeo, Allan Patrick |
author_sort | Quimque, Mark Tristan |
collection | PubMed |
description | [Image: see text] Inhibition of the major cyclic adenosine monophosphate-metabolizing enzyme PDE4 has shown potential for the discovery of drugs for cancer, inflammation, and neurodegenerative disorders such as Alzheimer’s disease. As a springboard to explore new anti-cancer and anti-Alzheimer’s chemical prototypes from rare Annonaceae species, the present study evaluated anti-PDE4B along with antiproliferative and anti-cholinesterase activities of the extracts of the Philippine endemic species Uvaria alba using in vitro assays and framed the resulting biological significance through computational binding and reactivity-based experiments. Thus, the PDE4 B2B-inhibiting dichloromethane sub-extract (UaD) of U. alba elicited antiproliferative activity against chronic myelogenous leukemia (K-562) and cytostatic effects against human cervical cancer (HeLa). The extract also profoundly inhibited acetylcholinesterase (AChE), an enzyme involved in the progression of neurodegenerative diseases. Chemical profiling analysis of the bioactive extract identified 18 putative secondary metabolites. Molecular docking and molecular dynamics simulations showed strong free energy binding mechanisms and dynamic stability at 50-ns simulations in the catalytic domains of PDE4 B2B, ubiquitin-specific peptidase 14, and Kelch-like ECH-associated protein 1 (KEAP-1 Kelch domain) for the benzylated dihydroflavone dichamanetin (16), and of an AChE and KEAP-1 BTB domain for 3-(3,4-dihydroxybenzyl)-3′,4′,6-trihydroxy-2,4-dimethoxychalcone (8) and grandifloracin (15), respectively. Density functional theory calculations to demonstrate Michael addition reaction of the most electrophilic metabolite and kinetically stable grandifloracin (15) with Cys151 of the KEAP-1 BTB domain illustrated favorable formation of a β-addition adduct. The top-ranked compounds also conferred favorable in silico pharmacokinetic properties. |
format | Online Article Text |
id | pubmed-8015132 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-80151322021-04-02 Potential Cancer- and Alzheimer’s Disease-Targeting Phosphodiesterase Inhibitors from Uvaria alba: Insights from In Vitro and Consensus Virtual Screening Quimque, Mark Tristan Notarte, Kin Israel Letada, Arianne Fernandez, Rey Arturo Pilapil, Delfin Yñigo Pueblos, Kirstin Rhys Agbay, Jay Carl Dahse, Hans-Martin Wenzel-Storjohann, Arlette Tasdemir, Deniz Khan, Abbas Wei, Dong-Qing Gose Macabeo, Allan Patrick ACS Omega [Image: see text] Inhibition of the major cyclic adenosine monophosphate-metabolizing enzyme PDE4 has shown potential for the discovery of drugs for cancer, inflammation, and neurodegenerative disorders such as Alzheimer’s disease. As a springboard to explore new anti-cancer and anti-Alzheimer’s chemical prototypes from rare Annonaceae species, the present study evaluated anti-PDE4B along with antiproliferative and anti-cholinesterase activities of the extracts of the Philippine endemic species Uvaria alba using in vitro assays and framed the resulting biological significance through computational binding and reactivity-based experiments. Thus, the PDE4 B2B-inhibiting dichloromethane sub-extract (UaD) of U. alba elicited antiproliferative activity against chronic myelogenous leukemia (K-562) and cytostatic effects against human cervical cancer (HeLa). The extract also profoundly inhibited acetylcholinesterase (AChE), an enzyme involved in the progression of neurodegenerative diseases. Chemical profiling analysis of the bioactive extract identified 18 putative secondary metabolites. Molecular docking and molecular dynamics simulations showed strong free energy binding mechanisms and dynamic stability at 50-ns simulations in the catalytic domains of PDE4 B2B, ubiquitin-specific peptidase 14, and Kelch-like ECH-associated protein 1 (KEAP-1 Kelch domain) for the benzylated dihydroflavone dichamanetin (16), and of an AChE and KEAP-1 BTB domain for 3-(3,4-dihydroxybenzyl)-3′,4′,6-trihydroxy-2,4-dimethoxychalcone (8) and grandifloracin (15), respectively. Density functional theory calculations to demonstrate Michael addition reaction of the most electrophilic metabolite and kinetically stable grandifloracin (15) with Cys151 of the KEAP-1 BTB domain illustrated favorable formation of a β-addition adduct. The top-ranked compounds also conferred favorable in silico pharmacokinetic properties. American Chemical Society 2021-03-16 /pmc/articles/PMC8015132/ /pubmed/33817501 http://dx.doi.org/10.1021/acsomega.1c00137 Text en © 2021 The Authors. Published by American Chemical Society Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Quimque, Mark Tristan Notarte, Kin Israel Letada, Arianne Fernandez, Rey Arturo Pilapil, Delfin Yñigo Pueblos, Kirstin Rhys Agbay, Jay Carl Dahse, Hans-Martin Wenzel-Storjohann, Arlette Tasdemir, Deniz Khan, Abbas Wei, Dong-Qing Gose Macabeo, Allan Patrick Potential Cancer- and Alzheimer’s Disease-Targeting Phosphodiesterase Inhibitors from Uvaria alba: Insights from In Vitro and Consensus Virtual Screening |
title | Potential Cancer- and Alzheimer’s Disease-Targeting
Phosphodiesterase Inhibitors from Uvaria alba: Insights from In Vitro and Consensus Virtual Screening |
title_full | Potential Cancer- and Alzheimer’s Disease-Targeting
Phosphodiesterase Inhibitors from Uvaria alba: Insights from In Vitro and Consensus Virtual Screening |
title_fullStr | Potential Cancer- and Alzheimer’s Disease-Targeting
Phosphodiesterase Inhibitors from Uvaria alba: Insights from In Vitro and Consensus Virtual Screening |
title_full_unstemmed | Potential Cancer- and Alzheimer’s Disease-Targeting
Phosphodiesterase Inhibitors from Uvaria alba: Insights from In Vitro and Consensus Virtual Screening |
title_short | Potential Cancer- and Alzheimer’s Disease-Targeting
Phosphodiesterase Inhibitors from Uvaria alba: Insights from In Vitro and Consensus Virtual Screening |
title_sort | potential cancer- and alzheimer’s disease-targeting
phosphodiesterase inhibitors from uvaria alba: insights from in vitro and consensus virtual screening |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015132/ https://www.ncbi.nlm.nih.gov/pubmed/33817501 http://dx.doi.org/10.1021/acsomega.1c00137 |
work_keys_str_mv | AT quimquemarktristan potentialcancerandalzheimersdiseasetargetingphosphodiesteraseinhibitorsfromuvariaalbainsightsfrominvitroandconsensusvirtualscreening AT notartekinisrael potentialcancerandalzheimersdiseasetargetingphosphodiesteraseinhibitorsfromuvariaalbainsightsfrominvitroandconsensusvirtualscreening AT letadaarianne potentialcancerandalzheimersdiseasetargetingphosphodiesteraseinhibitorsfromuvariaalbainsightsfrominvitroandconsensusvirtualscreening AT fernandezreyarturo potentialcancerandalzheimersdiseasetargetingphosphodiesteraseinhibitorsfromuvariaalbainsightsfrominvitroandconsensusvirtualscreening AT pilapildelfinynigo potentialcancerandalzheimersdiseasetargetingphosphodiesteraseinhibitorsfromuvariaalbainsightsfrominvitroandconsensusvirtualscreening AT puebloskirstinrhys potentialcancerandalzheimersdiseasetargetingphosphodiesteraseinhibitorsfromuvariaalbainsightsfrominvitroandconsensusvirtualscreening AT agbayjaycarl potentialcancerandalzheimersdiseasetargetingphosphodiesteraseinhibitorsfromuvariaalbainsightsfrominvitroandconsensusvirtualscreening AT dahsehansmartin potentialcancerandalzheimersdiseasetargetingphosphodiesteraseinhibitorsfromuvariaalbainsightsfrominvitroandconsensusvirtualscreening AT wenzelstorjohannarlette potentialcancerandalzheimersdiseasetargetingphosphodiesteraseinhibitorsfromuvariaalbainsightsfrominvitroandconsensusvirtualscreening AT tasdemirdeniz potentialcancerandalzheimersdiseasetargetingphosphodiesteraseinhibitorsfromuvariaalbainsightsfrominvitroandconsensusvirtualscreening AT khanabbas potentialcancerandalzheimersdiseasetargetingphosphodiesteraseinhibitorsfromuvariaalbainsightsfrominvitroandconsensusvirtualscreening AT weidongqing potentialcancerandalzheimersdiseasetargetingphosphodiesteraseinhibitorsfromuvariaalbainsightsfrominvitroandconsensusvirtualscreening AT gosemacabeoallanpatrick potentialcancerandalzheimersdiseasetargetingphosphodiesteraseinhibitorsfromuvariaalbainsightsfrominvitroandconsensusvirtualscreening |